AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$LFMD

LifeMD to Report Third Quarter 2026 Financial Results on November 9

LifeMD (LFMD) will release Q3 2026 financial results on November 9, 2026, before market open, followed by a conference call at 8:30 a.m. ET. The company provides virtual primary care and pharmacy services.

Original reporting
finance.yahoo.com
Published Oct 20, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
LifeMD to Report Third Quarter 2026 Financial Results on November 9 — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$LFMDNeutralLow
01

Why it matters

The filing is a standard earnings‑date announcement with no new financial metrics, offering limited trading impetus.

02

Market read

A routine earnings‑date notice; minimal immediate market impact.

03

What to watch

Potential regulatory changes or partnership announcements that could be disclosed in the upcoming earnings.

Relevance 4/10Novelty 3/10Timing: pre‑market on Nov 9

Background

LifeMD (Nasdaq: LFMD) provides virtual primary care and pharmacy services across the U.S.

Company-level read

Ticker impact

$LFMDNeutralMedium confidence
Context

LifeMD announced it will report its Q3 2026 results on November 9 before market open.

Expected impact

possible slight pressure as traders price in upcoming earnings uncertainty

Evidence & confidence

No financial numbers are disclosed; the news is a routine earnings‑date notice, offering limited actionable insight.

Market effects

Sector

None significant; virtual‑care sector may see modest attention ahead of the report.

Regional

U.S. market only, limited broader impact.

Global

Low

Counterpoint

What could challenge this read

Investors could ignore the date and focus on longer‑term growth trends in telehealth rather than short‑term positioning.

Key entities

  • Company
    LifeMD, Inc.

    Virtual primary‑care and pharmacy provider.

Read at source← All news

Related articles

$LFMDMed

LifeMD Nov 2026 slides: platform scale grows amid revenue reset

LifeMD (LFMD) presented its investor deck, highlighting revenue growth from $11M in 2019 to an expected $190M in 2026. Q3 revenue missed expectations at $44.6M, and the stock fell 17.59%. The company emphasized its telehealth platform's scale, AI integration, and nationwide pharmacy infrastructure, serving 350,000 active patients. LifeMD reset 2026 guidance to $188M-$191M revenue and negative EBITDA, citing delayed GLP-1 fulfillment and reduced marketing.

investing.com
$LFMDMed

Why is LifeMD stock sliding today?

LifeMD (LFMD) stock fell 9.4% after reporting Q3 2026 revenue of $44.6M, missing estimates of $48.9M. The company cut its full-year revenue outlook to $188M-$191M and widened its EBITDA loss forecast. Additionally, an accounting investigation and securities inquiry weighed on sentiment.

investing.com
$LFMDMed

LifeMD Reports Third Quarter 2026 Results

LifeMD, Inc. (LFMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 LifeMD Reports Third Quarter 2026 Results ● Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, within the Company’s guidance range of negative $1 million to positive $2 million. ● Adjusted EBITDA improved approximately $3

SEC EDGAR 8-K
$LFMDMed

LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

LifeMD (LFMD) partnered with AT&T to offer free virtual-health memberships to 29 million eligible customers in 11 states, with a nationwide expansion planned for 2027. The $19 monthly fee is waived, but services like visits and prescriptions remain payable. LifeMD aims to convert access into recurring demand for paid care, potentially reducing acquisition costs and benefiting from repeat consultations. The phased rollout allows for measuring enrollment and utilization before expansion.

yahoo.com
$TMed

AT&T Waives $19 LifeMD Fee for 100 Million Wireless and Fiber Customers

AT&T is partnering with LifeMD to waive its $19 monthly membership fee for over 100 million wireless and fiber customers, making it the first carrier to bundle no-cost virtual healthcare access. The rollout begins in 11 states, with the rest following in January 2027. LifeMD (LFMD) provides telehealth services, and AT&T aims to enhance customer retention. AT&T's stock is valued at $29.03 per share, with projected slight earnings declines due to heavy capital spending.

kobaran.com